Oct 21, 2018 | Publication
As a result of years of collaborative investment in training Nigerian scientists, genomic information about Lassa virus enabled public health officials to make real-time management decisions during the 2018 uptick in cases. Mounting a collaborative, real-time response...
Aug 9, 2018 | Publication
In two papers published in Cell and Cell Host Microbe VHFC investigators describe in detail antibody responses to Ebola virus. By systematic analysis of a large set of more than 170 monoclonal antibodies to Ebola virus, the researchers show which immunological...
Jul 30, 2018 | Publication
VHFC Scientists conducting the first comprehensive study of key immune system cells – collected from West African Ebola survivors – that kill Ebola infected cells have made a surprising discovery that provides important clues to developing effective...
Apr 12, 2018 | Publication
A new study from VHFC researchers in the journal Scientific Reports provide validation for a new rapid diagnostic test for Lassa fever. It is difficult to distinguish febrile illnesses that are common in West Africa from Lassa fever based solely on a patient’s...
Mar 26, 2018 | Press release
VHFC partner, Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases including Lassa fever (LF), today announced that The National Institutes of Health (NIH) has awarded Zalgen a Phase I grant to advance...
Mar 12, 2018 | Publication
A team of scientists at led by Pardis Sabeti at the Broad Institute has published a study that presents detailed clinical and laboratory data for Nigerian patients with Lassa fever. The authors did a multi-year large-scale retrospective, observational cohort study of...
Feb 27, 2018 | Press release
With a new $15 million grant, VHFC scientists at Scripps Research are gearing up for an in-depth study of survivors of viral outbreaks. The grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases will support the efforts of...
Jul 12, 2017 | Press release
The National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa. The NIH’s National Institute of Allergy and...
Jun 5, 2017 | Publication
A team of scientists at Scripps Research (Scripps Research) in La Jolla, California has published a study that shows the structure of the viral machinery that Lassa virus uses to enter human cells. The Scripps Research team, led by VHFC researcher Dr. Erica Ollmann...
May 29, 2017 | Publication
Members of the Viral Hemorrhagic Fever Consortium recently published a series of papers that show how Zika virus spread across South America, the Caribbean, and into the United States. The researchers used sequencing technology to collect genomic data that allowed...
